Home

Imaginativo combinar Nuestra compañía steatotest calculator baloncesto Hazlo pesado inventar

Comparison of fatty liver index with noninvasive methods for steatosis  detection and quantification
Comparison of fatty liver index with noninvasive methods for steatosis detection and quantification

How can we predict steatosis using biochemical markers (SteatoTest and  Fatty liver index) | Semantic Scholar
How can we predict steatosis using biochemical markers (SteatoTest and Fatty liver index) | Semantic Scholar

PDF) How can we predict steatosis using biochemical markers (SteatoTest and  Fatty liver index)?
PDF) How can we predict steatosis using biochemical markers (SteatoTest and Fatty liver index)?

Clinical case: NAFLD
Clinical case: NAFLD

Non-invasive assessment of non-alcoholic fatty liver disease: Clinical  prediction rules and blood-based biomarkers - ScienceDirect
Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers - ScienceDirect

Utility of noninvasive methods for the characterization of nonalcoholic  liver steatosis in the family practice. The “VARES” Italian multicenter  study | Annals of Hepatology
Utility of noninvasive methods for the characterization of nonalcoholic liver steatosis in the family practice. The “VARES” Italian multicenter study | Annals of Hepatology

Biomedicines | Free Full-Text | Effects of Achieving Sustained Virologic  Response after Direct-Acting Antiviral Agents on Long-Term Liver Fibrosis  in Diabetics vs. in Non-Diabetic Patients with Chronic Hepatitis C Infection
Biomedicines | Free Full-Text | Effects of Achieving Sustained Virologic Response after Direct-Acting Antiviral Agents on Long-Term Liver Fibrosis in Diabetics vs. in Non-Diabetic Patients with Chronic Hepatitis C Infection

How can we predict steatosis using biochemical markers (SteatoTest and  Fatty liver index) | Semantic Scholar
How can we predict steatosis using biochemical markers (SteatoTest and Fatty liver index) | Semantic Scholar

Diagnostics | Free Full-Text | Diagnostic Modalities of Non-Alcoholic Fatty  Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive  Approaches
Diagnostics | Free Full-Text | Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches

Comparison of fatty liver index with noninvasive methods for steatosis  detection and quantification
Comparison of fatty liver index with noninvasive methods for steatosis detection and quantification

Diagnostics | Free Full-Text | Diagnostic Modalities of Non-Alcoholic Fatty  Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive  Approaches
Diagnostics | Free Full-Text | Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches

The diagnostic performance of a simplified blood test (SteatoTest-2) for  the prediction of liver steatosis
The diagnostic performance of a simplified blood test (SteatoTest-2) for the prediction of liver steatosis

Comparison of fatty liver index with noninvasive methods for steatosis  detection and quantification
Comparison of fatty liver index with noninvasive methods for steatosis detection and quantification

How can we predict steatosis using biochemical markers (SteatoTest and  Fatty liver index) | Semantic Scholar
How can we predict steatosis using biochemical markers (SteatoTest and Fatty liver index) | Semantic Scholar

European Association for the Study of the Liver (EASL), European  Association for the Study of Diabetes (EASD) and European Association for  the Study of Obesity (EASO) clinical practice recommendations for the  management
European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD) and European Association for the Study of Obesity (EASO) clinical practice recommendations for the management

PDF) How can we predict steatosis using biochemical markers (SteatoTest and  Fatty liver index)?
PDF) How can we predict steatosis using biochemical markers (SteatoTest and Fatty liver index)?

PDF) The diagnostic performance of a simplified blood test (SteatoTest-2)  for the prediction of liver steatosis
PDF) The diagnostic performance of a simplified blood test (SteatoTest-2) for the prediction of liver steatosis

Performance of Biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in  Patients with Severe Obesity: Meta Analysis of Individual Patient Data |  PLOS ONE
Performance of Biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in Patients with Severe Obesity: Meta Analysis of Individual Patient Data | PLOS ONE

PDF) The diagnostic value of biomarkers (SteatoTest) for the prediction of  liver steatosis
PDF) The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis

The diagnostic performance of a simplified blood test (SteatoTest-2) for  the prediction of liver steatosis
The diagnostic performance of a simplified blood test (SteatoTest-2) for the prediction of liver steatosis

Dihydroceramides in Triglyceride-Enriched VLDL Are Associated with  Nonalcoholic Fatty Liver Disease Severity in Type 2 Diabetes - ScienceDirect
Dihydroceramides in Triglyceride-Enriched VLDL Are Associated with Nonalcoholic Fatty Liver Disease Severity in Type 2 Diabetes - ScienceDirect